A detailed history of Capital Investment Services Of America, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Capital Investment Services Of America, Inc. holds 3,232 shares of ABT stock, worth $411,724. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,232
Previous 3,082 4.87%
Holding current value
$411,724
Previous $351,000 3.99%
% of portfolio
0.04%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

BUY
$111.93 - $119.39 $16,789 - $17,908
150 Added 4.87%
3,232 $365,000
Q3 2024

Oct 30, 2024

SELL
$100.07 - $118.13 $40,528 - $47,842
-405 Reduced 11.61%
3,082 $351,000
Q2 2024

Jul 19, 2024

SELL
$100.73 - $112.44 $25,182 - $28,110
-250 Reduced 6.69%
3,487 $362,000
Q1 2024

May 13, 2024

SELL
$109.52 - $120.96 $60,674 - $67,011
-554 Reduced 12.91%
3,737 $424,000
Q3 2023

Oct 13, 2023

SELL
$95.53 - $114.62 $6,400 - $7,679
-67 Reduced 1.54%
4,291 $415,000
Q2 2023

Jul 11, 2023

SELL
$100.78 - $112.29 $1,511 - $1,684
-15 Reduced 0.34%
4,358 $475,000
Q4 2022

Jan 26, 2023

SELL
$95.06 - $111.52 $16,825 - $19,739
-177 Reduced 3.89%
4,373 $0
Q3 2022

Oct 03, 2022

BUY
$96.76 - $112.03 $17,126 - $19,829
177 Added 4.05%
4,550 $440,000
Q4 2021

Jan 07, 2022

SELL
$115.53 - $141.46 $4,043 - $4,951
-35 Reduced 0.79%
4,373 $615,000
Q1 2021

Apr 06, 2021

SELL
$108.84 - $128.23 $1,741 - $2,051
-16 Reduced 0.36%
4,408 $528,000
Q4 2020

Jan 06, 2021

BUY
$105.0 - $114.42 $113,505 - $123,688
1,081 Added 32.34%
4,424 $484,000
Q3 2018

Oct 05, 2018

SELL
$60.81 - $73.36 $2,006 - $2,420
-33 Reduced 0.98%
3,343 $245,000
Q1 2018

Apr 05, 2018

SELL
$56.27 - $63.62 $13,786 - $15,586
-245 Reduced 6.77%
3,376 $202,000
Q4 2017

Jan 09, 2018

BUY
$53.68 - $57.47 $194,375 - $208,098
3,621
3,621 $207,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $223B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Capital Investment Services Of America, Inc. Portfolio

Follow Capital Investment Services Of America, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Services Of America, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Services Of America, Inc. with notifications on news.